The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Trend of TI values with age: The TI values decreased significantly with the increase of age, * p<0.01 vs other groups. by Yunmeng Da (707943)

Combined decitabine and Taxol decreases MCF-7/Taxol cells proliferation and can improve their chemosensitivity. by Weihua Gong (471435)

Main performance indicators of BF. by Yao Long (1604773)

Subjects:

NH₃ concentration decrease at different distances. by Haibao Yi (17666896)

Subjects:

Significant main effect of housing type. by Grace Hecker (18813445)

Significant interactions and main effects of day. by Grace Hecker (18813445)

Behaviors with a significant main effect or interaction. by Grace Hecker (18813445)

Increasing and decreasing temperature trends in <i>M</i>. <i>peregrina</i> habitats at 95% confidence level. by Hossein Piri Sahragard (19226096)

Subjects:

Statistical significance of performance improvements. by Miao Deng (1860859)

Statistical results of the two-way ANOVA with repeated measures on the interaction and main effects of the pressure and duration factors of cupping therapy. by Isabella Yu-Ju Hung (18264728)

Subjects:

Significant main effect of age showing decreased gray matter volume in nearly the entire cortical brain and subcortical cortex. by Zhiliang Long (306092)

Main characteristics of the included trials. by Yuan-yuan WANG (19370071)

“…Three months use of HCL show a beneficial effect on HbA1c management (<i>p</i> <0.001) as compared to standard of care in adolescents and children with T1D, without evidence of heterogeneity between articles (<i>I</i>² = 40%, <i>p</i> = 0.10). HCL did significantly increase the overall average percentage of hypoglycemic time between 70 and 180 mg/dL (TIR) (<i>p</i> <0.001; <i>I</i>² = 51%). …”

Main pathway changes after caloric restriction (CR) and partial recovery (PR) compared to ad libitum controls. by Manuel A. Cornejo (11636656)

Subjects:

DSC improvement as number of training images increases. by Kimia Aghamohammadesmaeilketabforoosh (21175384)

The evaluation of the CAFs marker on each treatment day. by Yoshiaki Tadokoro (16851585)

Subjects:

The effect of transcutaneous CO₂ treatment. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for tumor volume and body weight. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for immunohistochemical evaluation, IRS score. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for quantitative real-time polymerase chain reaction analysis. by Yoshiaki Tadokoro (16851585)

Subjects: